1 - 10 of 40 articles
NOTIFY, an online library of international adverse events and reactions in transplantation and assisted reproduction, is scheduled to launch next year. “The AJT Report” investigates the benefits and challenges of such an endeavor. Also this month, we report on two Alabama Organ Center...
While we have learned much about the immune system and devised many important and useful drugs, tolerance seems to remain a distant goal on the horizon. A new study shows that the tumor microenvironment may reveal some of the most important determinants of tolerance.
On examining two studies exposing substantial variation in liver transplant exception awards, the author asks, how much variation in health care delivery is acceptable? See articles by Argo et al (page 2353) and Massie et al (page 2362).
The author reviews the evidence that addresses the use of mTOR inhibitors in hepatitis C virus–infected liver grafts, focusing in particular on its reported beneficial effect on fibrosis. See article by McKenna et al on page 2379.
This editorial provides a perspective on the milestones and current issues that relate to risk assessment in transplant recipients considering parenthood. See article by Deshpande et al on page 2388.
The author provides perspective on clinical application of C5‐specific antibody therapy for terminal complement inhibition in kidney transplantation. See article by Stegall et al on page 2405.
Acute kidney injury occurs with kidney transplantation and too frequently progresses to the clinical diagnosis of delayed graft function (DGF). Poor kidney function in the first week of graft life is detrimental to the longevity of the allograft. Challenges to understand the root cause of DGF...
Over the last decade, many investigators have utilized bone marrow‐derived cells for cell transplantation therapy in animal studies and in patients with acute myocardial infarction and chronic heart failure. In those experimental and clinical studies, various doses and types of bone...
The estimated incidence of end‐stage renal disease (ESRD) in Pakistan is 100 per million population. Paucity and high costs of renal replacement therapy allows only 10% to get dialysis and 4–5% transplants. Our center, a government organization, started a dialysis and transplant program in 1980s...
Breakthroughs in basic and clinical science in solid organ transplantation were presented at the American Transplant Congress 2011. Key areas of presentation included the pathogenesis of late allograft failure, immune regulation and tolerance, pathways in allograft injury, electing appropriate...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.